Last update:

Weight management news

Food noise: Why thoughts about eating aren't always something to be feared

When you're hungry, it's normal to find yourself thinking about what you're going to eat next.

Roux-en-Y gastric bypass, sleeve gastrectomy cost-effective for teens with severe obesity

Both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy are cost-effective compared with no surgery for adolescents with severe obesity, according to a study published online June 15 in JAMA Network Open.

Excess belly fat linked to faster biological aging

New research suggests that higher levels of visceral fat, the fat stored deep in the abdomen, could contribute to faster biological aging in middle-aged adults. Adjunct Associate Professors Jennie Hui and Kun Zhu, from The ...

Will GLP-1s lead to fewer prescriptions for older adults?

As people age, they often develop chronic conditions, many of which need to be managed with multiple prescription medications. While medications are important for disease management, polypharmacy poses an increased risk for ...

New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks

A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...

'Food noise' discussion on social media helps define the term

With the rise of weight-loss drugs such as GLP-1 medications in recent years, the phrase "food noise" has taken off, particularly in conversations about health and wellness on social media. While thinking about food during ...

Can't stick to a diet? Try intermittent fasting for weight loss

Yo-yo dieters who struggle to lose weight and keep it off may achieve better results by following an intermittent fasting diet, rather than traditional calorie counting. An Adelaide University study focusing on the psychological ...

Why weight‑loss drugs don't work for some people

Weight-loss jabs are the latest craze for shedding a few pounds. Their effect has been dramatic, with drugs such as Ozempic and Wegovy (semaglutide) causing users to lose up to 15% of their body fat on average.

Beyond GLP-1s: The next chapter of obesity care

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most pressing chronic diseases.